Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

Valerio Renzelli,Marco Gallo,Lelio Morviducci,Giampiero Marino,Alberto Ragni,Enzo Tuveri,Antongiulio Faggiano,Rossella Mazzilli,Annalisa Natalicchio,Maria Chiara Zatelli,Monica Montagnani,Stefano Fogli,Dario Giuffrida,Antonella Argentiero,Romano Danesi,Stella D’Oronzo,Stefania Gori,Tindara Franchina,Antonio Russo,Matteo Monami,Laura Sciacca,Saverio Cinieri,Annamaria Colao,Angelo Avogaro,Graziano Di Cianni,Francesco Giorgino,Nicola Silvestris
DOI: https://doi.org/10.3390/cancers15174237
2023-08-25
Cancers
Abstract:There is increasing evidence of the role of endocrine disruptors (EDs) derived from commonly employed compounds for manufacturing and processing in altering hormonal signaling and function. Due to their prolonged half-life and persistence, EDs can usually be found not only in industrial products but also in households and in the environment, creating the premises for long-lasting exposure. Polybrominated diphenyl ethers (PBDEs) are common EDs used in industrial products such as flame retardants, and recent studies are increasingly showing that they may interfere with both metabolic and oncogenic pathways. In this article, a multidisciplinary panel of experts of the Italian Association of Medical Diabetologists (AMD), the Italian Society of Diabetology (SID), the Italian Association of Medical Oncology (AIOM), the Italian Society of Endocrinology (SIE) and the Italian Society of Pharmacology (SIF) provides a review on the potential role of PBDEs in human health and disease, exploring both molecular and clinical aspects and focusing on metabolic and oncogenic pathways.
oncology
What problem does this paper attempt to address?